Bleakley Financial Group LLC increased its holdings in shares of Kimberly-Clark Corporation (NASDAQ:KMB - Free Report) by 164.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,350 shares of the company's stock after purchasing an additional 17,008 shares during the quarter. Bleakley Financial Group LLC's holdings in Kimberly-Clark were worth $2,759,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Kestra Investment Management LLC increased its position in Kimberly-Clark by 83.1% during the fourth quarter. Kestra Investment Management LLC now owns 6,208 shares of the company's stock valued at $626,000 after acquiring an additional 2,817 shares during the last quarter. Allied Investment Advisors LLC increased its position in Kimberly-Clark by 10.1% during the fourth quarter. Allied Investment Advisors LLC now owns 88,679 shares of the company's stock valued at $8,947,000 after acquiring an additional 8,106 shares during the last quarter. Harbour Investments Inc. increased its position in Kimberly-Clark by 24.0% during the fourth quarter. Harbour Investments Inc. now owns 21,840 shares of the company's stock valued at $2,203,000 after acquiring an additional 4,233 shares during the last quarter. Allstate Corp increased its position in Kimberly-Clark by 103.7% during the fourth quarter. Allstate Corp now owns 24,845 shares of the company's stock valued at $2,507,000 after acquiring an additional 12,650 shares during the last quarter. Finally, Summitry LLC increased its position in Kimberly-Clark by 9.7% during the fourth quarter. Summitry LLC now owns 50,674 shares of the company's stock valued at $5,112,000 after acquiring an additional 4,487 shares during the last quarter. 76.29% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have commented on KMB shares. Barclays reduced their price target on Kimberly-Clark from $105.00 to $99.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 14th. Deutsche Bank Aktiengesellschaft reduced their price target on Kimberly-Clark from $110.00 to $109.00 and set a "hold" rating for the company in a research report on Monday, March 30th. UBS Group upped their price target on Kimberly-Clark from $105.00 to $106.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 29th. Weiss Ratings restated a "hold (c-)" rating on shares of Kimberly-Clark in a research report on Friday, March 27th. Finally, Piper Sandler decreased their price objective on shares of Kimberly-Clark from $133.00 to $114.00 and set an "overweight" rating on the stock in a research report on Friday, March 13th. Four equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $114.93.
Read Our Latest Stock Report on KMB
Kimberly-Clark Stock Performance
NASDAQ:KMB opened at $100.18 on Thursday. The company has a current ratio of 0.77, a quick ratio of 0.55 and a debt-to-equity ratio of 3.38. Kimberly-Clark Corporation has a 12-month low of $92.42 and a 12-month high of $144.30. The stock has a 50-day moving average price of $97.72 and a 200 day moving average price of $101.36. The stock has a market capitalization of $33.25 billion, a P/E ratio of 15.73, a P/E/G ratio of 4.43 and a beta of 0.29.
Kimberly-Clark (NASDAQ:KMB - Get Free Report) last released its earnings results on Tuesday, April 28th. The company reported $1.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.04. The firm had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.09 billion. Kimberly-Clark had a return on equity of 152.79% and a net margin of 12.80%.The firm's revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the business posted $1.93 earnings per share. Equities research analysts forecast that Kimberly-Clark Corporation will post 7.48 EPS for the current fiscal year.
Kimberly-Clark Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 2nd. Shareholders of record on Friday, June 5th will be paid a $1.28 dividend. The ex-dividend date of this dividend is Friday, June 5th. This represents a $5.12 dividend on an annualized basis and a yield of 5.1%. Kimberly-Clark's payout ratio is presently 80.38%.
Insider Buying and Selling
In other Kimberly-Clark news, VP Andrew Scribner sold 4,095 shares of Kimberly-Clark stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $98.00, for a total value of $401,310.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Katy Chen sold 1,596 shares of Kimberly-Clark stock in a transaction that occurred on Monday, May 4th. The stock was sold at an average price of $95.34, for a total value of $152,162.64. Following the completion of the sale, the insider directly owned 8,362 shares in the company, valued at approximately $797,233.08. The trade was a 16.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 7,096 shares of company stock worth $689,687. Corporate insiders own 0.75% of the company's stock.
Kimberly-Clark Profile
(
Free Report)
Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.
Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report